Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Neoplasia (New York, N.Y.)|December 18, 2016
Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide TherapyLatifa Rbah-Vidal, Aurélien Vidal, Emilie M F Billaud, et al.
BMC Cancer|April 16, 2022
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocolEmilie Thivat, Jacques Rouanet, Philippe Auzeloux, et al.
International Journal of Cancer|May 14, 2009
Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agentMathilde Bonnet-Duquennoy, Janine Papon, Florence Mishellany, et al.
International Journal of Cancer|February 14, 2013
In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide moleculeFrançoise Degoul, Michèle Borel, Nathalie Jacquemot, et al.
Investigational New Drugs|April 3, 2014
Evaluation of two (125)I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanomaMaryline Gardette, Claire Viallard, Salomé Paillas, et al.
Journal of Medicinal Chemistry|September 5, 2025
Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast CancerEtienne Auvert, Emmanuel Douez, Louis Jolivet, et al.
European Journal of Medicinal Chemistry|April 23, 2013
Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probesAurélie Maisonial, Emilie M F Billaud, Sophie Besse, et al.
Nanoscale|January 22, 2013
Development of gadolinium based nanoparticles having an affinity towards melaninJessica Morlieras, Jean-Michel Chezal, Elisabeth Miot-Noirault, et al.
Pageof 9